Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmacon, historically known as Pharmacon-St. Petersburg, was a prominent Russian pharmaceutical manufacturer based in Saint Petersburg with a legacy dating back to the early 20th century. The company was a key player in the Soviet and Russian pharmaceutical industries, specializing in the production of essential small molecule drugs, including the widely used antiviral Umifenovir (Arbidol) and the benzodiazepine Phenazepam. Pharmacon operated significant manufacturing facilities and was instrumental in the development and commercialization of several original Soviet-era medications. In 2005, the company was acquired by the Russian pharmaceutical giant Sintez, and its operations were subsequently integrated into the broader Binnopharm Group, marking the end of its independent existence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacon.